rs163150

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000218.3(KCNQ1):​c.1685+36A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.677 in 1,522,216 control chromosomes in the GnomAD database, including 349,086 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.66 ( 33412 hom., cov: 33)
Exomes 𝑓: 0.68 ( 315674 hom. )

Consequence

KCNQ1
NM_000218.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -1.25

Publications

18 publications found
Variant links:
Genes affected
KCNQ1 (HGNC:6294): (potassium voltage-gated channel subfamily Q member 1) This gene encodes a voltage-gated potassium channel required for repolarization phase of the cardiac action potential. This protein can form heteromultimers with two other potassium channel proteins, KCNE1 and KCNE3. Mutations in this gene are associated with hereditary long QT syndrome 1 (also known as Romano-Ward syndrome), Jervell and Lange-Nielsen syndrome, and familial atrial fibrillation. This gene exhibits tissue-specific imprinting, with preferential expression from the maternal allele in some tissues, and biallelic expression in others. This gene is located in a region of chromosome 11 amongst other imprinted genes that are associated with Beckwith-Wiedemann syndrome (BWS), and itself has been shown to be disrupted by chromosomal rearrangements in patients with BWS. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Aug 2011]
KCNQ1 Gene-Disease associations (from GenCC):
  • long QT syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • long QT syndrome 1
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • Jervell and Lange-Nielsen syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Jervell and Lange-Nielsen syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P
  • atrial fibrillation, familial, 3
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • short QT syndrome
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • short QT syndrome type 2
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • familial atrial fibrillation
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Jervell and Lange-Nielsen syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BP6
Variant 11-2776090-A-G is Benign according to our data. Variant chr11-2776090-A-G is described in ClinVar as Benign. ClinVar VariationId is 1264836.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.715 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KCNQ1NM_000218.3 linkc.1685+36A>G intron_variant Intron 13 of 15 ENST00000155840.12 NP_000209.2 P51787-1Q96AI9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KCNQ1ENST00000155840.12 linkc.1685+36A>G intron_variant Intron 13 of 15 1 NM_000218.3 ENSP00000155840.2 P51787-1

Frequencies

GnomAD3 genomes
AF:
0.661
AC:
100422
AN:
151994
Hom.:
33369
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.620
Gnomad AMI
AF:
0.565
Gnomad AMR
AF:
0.590
Gnomad ASJ
AF:
0.689
Gnomad EAS
AF:
0.709
Gnomad SAS
AF:
0.736
Gnomad FIN
AF:
0.735
Gnomad MID
AF:
0.656
Gnomad NFE
AF:
0.681
Gnomad OTH
AF:
0.647
GnomAD2 exomes
AF:
0.668
AC:
101051
AN:
151238
AF XY:
0.676
show subpopulations
Gnomad AFR exome
AF:
0.605
Gnomad AMR exome
AF:
0.551
Gnomad ASJ exome
AF:
0.679
Gnomad EAS exome
AF:
0.708
Gnomad FIN exome
AF:
0.747
Gnomad NFE exome
AF:
0.678
Gnomad OTH exome
AF:
0.661
GnomAD4 exome
AF:
0.678
AC:
929514
AN:
1370104
Hom.:
315674
Cov.:
25
AF XY:
0.680
AC XY:
459523
AN XY:
675698
show subpopulations
African (AFR)
AF:
0.620
AC:
19319
AN:
31182
American (AMR)
AF:
0.555
AC:
19723
AN:
35566
Ashkenazi Jewish (ASJ)
AF:
0.679
AC:
16879
AN:
24842
East Asian (EAS)
AF:
0.704
AC:
25033
AN:
35556
South Asian (SAS)
AF:
0.728
AC:
57284
AN:
78668
European-Finnish (FIN)
AF:
0.736
AC:
33372
AN:
45316
Middle Eastern (MID)
AF:
0.646
AC:
2834
AN:
4388
European-Non Finnish (NFE)
AF:
0.678
AC:
716726
AN:
1057602
Other (OTH)
AF:
0.673
AC:
38344
AN:
56984
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.513
Heterozygous variant carriers
0
15629
31259
46888
62518
78147
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18692
37384
56076
74768
93460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.661
AC:
100522
AN:
152112
Hom.:
33412
Cov.:
33
AF XY:
0.665
AC XY:
49496
AN XY:
74388
show subpopulations
African (AFR)
AF:
0.621
AC:
25762
AN:
41472
American (AMR)
AF:
0.590
AC:
9022
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.689
AC:
2392
AN:
3472
East Asian (EAS)
AF:
0.709
AC:
3652
AN:
5154
South Asian (SAS)
AF:
0.735
AC:
3543
AN:
4818
European-Finnish (FIN)
AF:
0.735
AC:
7800
AN:
10610
Middle Eastern (MID)
AF:
0.668
AC:
195
AN:
292
European-Non Finnish (NFE)
AF:
0.681
AC:
46272
AN:
67986
Other (OTH)
AF:
0.650
AC:
1370
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1783
3565
5348
7130
8913
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
812
1624
2436
3248
4060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.662
Hom.:
15044
Bravo
AF:
0.642
Asia WGS
AF:
0.731
AC:
2541
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Long QT syndrome 1 Benign:1
Aug 01, 2023
Molecular Genetics Laboratory - Cardiogenetics, CHU de Nantes
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.96
CADD
Benign
2.5
DANN
Benign
0.52
PhyloP100
-1.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs163150; hg19: chr11-2797320; COSMIC: COSV50126670; COSMIC: COSV50126670; API